3 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11▼ RSI OverboughtRSI 73.6, above 70, stock may be overbought
Jul 10▼ RSI OverboughtRSI 76.0, above 70, stock may be overbought
About USANA Health Sciences, Inc.
Part of the consumer defensive sector, USANA Health Sciences, Inc. (USNA) is listed under Packaged Foods. The $402.9M market capitalization puts USNA squarely in small-cap range for its industry. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer.
Premium feature
News & analytics is part of Premium.
Every headline runs through our finance-grade sentiment engine, so you see the mood of the market on each ticker before you read a single article. Plus the full analyst consensus and target-price upside, refreshed daily.
Per-headline sentiment, scored by a finance-tuned model
See exactly where the price sits versus its 150-day moving average, the live RSI reading, MACD momentum, and volume context, for any ticker, every day.
With $162.8M in cash and $14.0M in debt, USNA maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow comes in at $29.6M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 1.6% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.1% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $998.6M (2022) to $925.3M (2025).
With cash comfortably exceeding debt, USNA has financial flexibility that may help navigate uncertain periods. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing USNA.